245 related articles for article (PubMed ID: 21161440)
1. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
[TBL] [Abstract][Full Text] [Related]
2. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
3. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.
Choi JS; Kim EK; Moon HJ; Kwak JY
Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734
[TBL] [Abstract][Full Text] [Related]
4. Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.
Ye ZQ; Gu DN; Hu HY; Zhou YL; Hu XQ; Zhang XH
World J Surg Oncol; 2013 Mar; 11():56. PubMed ID: 23496874
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
6. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension.
Haymart MR; Glinberg SL; Liu J; Sippel RS; Jaume JC; Chen H
Clin Endocrinol (Oxf); 2009 Sep; 71(3):434-9. PubMed ID: 19067720
[TBL] [Abstract][Full Text] [Related]
7. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
[TBL] [Abstract][Full Text] [Related]
8. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
9. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
[TBL] [Abstract][Full Text] [Related]
11. The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers.
Besler E; Citgez B; Aygun N; Celayir MF; Ozguven MBY; Mihmanli M; Yetkin SG; Uludag M
Eurasian J Med; 2019 Feb; 51(1):8-11. PubMed ID: 30911248
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
13. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
[TBL] [Abstract][Full Text] [Related]
14. The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer.
Aydoğan Bİ; Mutlu ABB; Yüksel S; Güllü S; Emral R; Demir Ö; Şahin M; Gedik VT; Çorapçıoğlu D; Sak SD; Erdoğan MF
Endocr Pathol; 2021 Jun; 32(2):280-287. PubMed ID: 33188468
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Outcomes of Postoperative Recurrent Well-Differentiated Thyroid Cancer: A Single Institution's 15-Year Experience.
Amin SN; Shinn JR; Naguib MM; Netterville JL; Rohde SL
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):469-475. PubMed ID: 32069184
[TBL] [Abstract][Full Text] [Related]
16. Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
Bortz MD; Kuchta K; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2021 Jan; 169(1):2-6. PubMed ID: 32682508
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic Characteristics of Thyroid Microcarcinoma: Findings from a Hospital-Based Study in Vietnam.
Nguyen BQ; Vu HT; Nguyen LMT; Nguyen QH; Paragomi P; Luu HN
Discov Med; 2024 Jan; 36(180):209-216. PubMed ID: 38273761
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography.
Lee CY; Kim SJ; Ko KR; Chung KW; Lee JH
J Ultrasound Med; 2014 Feb; 33(2):231-8. PubMed ID: 24449725
[TBL] [Abstract][Full Text] [Related]
19. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.
Qu N; Zhang L; Lin DZ; Ji QH; Zhu YX; Wang Y
Tumour Biol; 2016 Jun; 37(6):7685-92. PubMed ID: 26692097
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
Zhang X; Zhang L; Xue S; Wang P; Chen G
Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
